Hutchison China MediTech Ltd. (Chi-Med) has filed an application for a new share listing on The Stock Exchange of Hong Kong (SEHK), to raise new financing designed mainly to move forward and take to market its growing oncology-focused pipeline.
While pricing has not been set and Chi-Med did not give any target, reports suggest that the listing – expected in the third quarter - could raise up